This summary was created by AI, based on 1 opinions in the last 12 months.
Globus Medical, with symbol GMED-N, is a smaller player in the medical parts business, similar to Stryker. Their sales have shown steady annual growth of about 12% over the past 5 years, and they also offer a software machine interface to assist with part installation. Experts also see an opportunity for the company in the Asian demographic tailwinds, indicating positive potential for future growth and market expansion.
He recommended it around 18 months ago, and it has doubled in price. Drawbacks before: had no international presence and not enough salespeople, but that has turned around, as reflected in the price jump. Earnings growing 10-15% annually. No debt, but pay no dividend. Buy half a position and watch, but don't buy heavily because it may
drop badly during a correction.
Since he recommended this, it’s gone from $22 to $46. This is medical technology for spying related injuries. The stock price has taken off because the company has gotten their act together and has started to move outside of the US. Their sales teams are in place. A lot of their competitors have not been allocating capital towards the spine business. This company just came out with a new robotic invention that will help surgeons do all the spine surgeries. Earnings have jumped up nicely, and he is expecting anywhere from $143-$178 a share over the next couple of years, but we are still seeing the stock trading at roughly 32X earnings. Wait for a pullback or just buy half for the moment.
This is a tiny little $2 billion company that is in robotics of spinal care. Growing at a wonderful rate, but the street hasn’t adapted to them.
Globus Medical is a American stock, trading under the symbol GMED-N on the New York Stock Exchange (GMED). It is usually referred to as NYSE:GMED or GMED-N
In the last year, 1 stock analyst published opinions about GMED-N. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Globus Medical.
Globus Medical was recommended as a Top Pick by on . Read the latest stock experts ratings for Globus Medical.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered Globus Medical In the last year. It is a trending stock that is worth watching.
On 2024-10-10, Globus Medical (GMED-N) stock closed at a price of $69.79.
Being in the medical parts business, it is like Stryker but much smaller. It also has a software machine interface that helps the installation of these parts. Sales have grown about 12% annually over the past 5 years. Also it is an opportunity for Asian demographic tailwinds.